Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 7, 2019
[Characteristics and prognosis in adult patients with early T-cell precursor acute lymphoblastic leukemia]X Y Gong, Y Wang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Efficacy and safety of IAC regimen for relapse/refractory acute myeloid leukemia: a prospective randomized controlled study]C H Li, S N Wei, S W Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Primary antifungal prophylaxis with posaconazole plays a pivotal role during chemotherapy of acute myeloid leukemia]B F Gong, Y T Liu, G J Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 9, 2022
[Comparison of the efficacy of IA and HAD induction regimens in the treatment of patients with newly diagnosed acute myeloid leukemia: a single-center study]C X Zhang, S W Qiu, B F Gong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 22, 2017
[Clinical features and prognosis in CD10(-) pre-B acute lymphoblastic leukemia]X Y Gong, Y Wang, B C Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 23, 2018
[Impact of duration of antibiotic therapy on the prognosis of patients with acute myeloid leukemia who had Gram-negative bloodstream infection in consolidation chemotherapy]R X Gu, H Wei, Y Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 15, 2021
[Dasatinib combined with multi-agent chemotherapy regimen in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a prospective study from a single center]G J Zhang, X Y Gong, S W Qiu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia]J Feng, X Y Gong, Y J Jia, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 28, 2017
[Prediction of outcome in acute myeloid leukemia by measurement of WT1 expression as a basic marker of minimal residual disease]N Zhao, H Wei, Y Wang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 2, 2016
[Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective, randomized controlled trial]Y Wang, B C Liu, H Wei, et al.
Pageof 5